Skip to main content
Fig. 2 | BMC Medical Research Methodology

Fig. 2

From: Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer

Fig. 2

Hazard-ratios of the Weighted Cumulative Exposure (WCE) model. Changes in HRs of death with increasing time from the day of dose intake, for patients who were administered 1, 2 or 10 dose with patients who received no doses as the reference (gray shaded area indicates the 95% pointwise confidence band interval for the HR for the “1 dose” exposure)

Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us